Cleerly adds $106M to Series C
Cleerly, a company that uses artificial intelligence to diagnose heart disease, announced the close of a $106 Series C extension funding round led by investment firm Insight Partners.
Venture capital firm Battery Ventures participated, among other existing company investors. Cleerly said it would use the new capital to continue scaling the business. A company spokesperson declined to share what portion of the extension round was debt or equity.
Related: Top digital health funding: Morgan Health backs autism startup
Cleerly uses a non-invasive imaging-based software to analyze plaque, narrowing of the arteries, and the likelihood of reduced blood flow — all potential signs of heart disease.
The company announced in July 2022 it had raised $223 million in a Series C funding round.
Merative secures $25M from Morgan Health
Merative, a healthcare data and analytics company, announced it secured a $25 million investment from Morgan Health, a healthcare-focused business unit of JPMorganChase.
The company was formed in July 2022 when private equity firm Francisco Partners purchased Watson Health from IBM for a reported $1 billion, using the assets to launch Merative. It sells data and analytics tools to customers such as self-insured employers, providers, life science companies and governments.
The investment, announced Tuesday, will allow Merative to scale its products and focus on providing additional data to self-insured employers. A company spokesperson declined to release the company’s total funding to date.
The investment is the second in as many weeks for Morgan Health, which recently co-led an $80 million round in autism-focused startup, Cortica, with venture capital firm Nexus NeuroTech Ventures.